New Diet Drugs Face FDA Scrutiny - corporatebreakingnews.com

Corporate Breaking News

Home : New Diet Drugs Face FDA Scrutiny

Apr 11 2011	New Diet Drugs Face FDA Scrutiny
The FDA rejected an application from drug maker Vivus to have Qnexa approved for the treatment of obesity, citing possible health risks. But the results of a phase 3 clinical trial reveal the magnitude of benefit.


Source:http://feeds.abcnews.com/click.phdo?i=69bef0791a48ca533b63cd536185cf0f

Related News
» Saving for House Down Payment » Announcing The IL Bridge Fund llc's Business Incubation Program for New and Emerging Businesses